Our additional preliminary studies demonstrate that dual targeting of multiple myeloma cells and BM-CAFs by CAR-T cells is ...

Nine of 11 patients in new brain cancer trial saw their tumors shrink by at least half. One really beat the odds.

Researchers led by Osaka University in Japan have conducted the first human trial using induced pluripotent stem-cell-derived ...